Ocean global warming tool sinks

A company that aimed to reduce global warming by creating blooms of carbon dioxide-absorbing phytoplankton in the ocean has sunk, linkurl:according to;http://www.nytimes.com/2008/02/14/technology/14planktos.html?_r=1&oref=slogin the New York Times. The company, Planktos, posted a linkurl:statement on its Web site;http://planktos.com/ yesterday (February 13) saying that it had decided to "indefinitely postpone its ocean fertilization efforts" as a result of a "highly effective disinf

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A company that aimed to reduce global warming by creating blooms of carbon dioxide-absorbing phytoplankton in the ocean has sunk, linkurl:according to;http://www.nytimes.com/2008/02/14/technology/14planktos.html?_r=1&oref=slogin the New York Times. The company, Planktos, posted a linkurl:statement on its Web site;http://planktos.com/ yesterday (February 13) saying that it had decided to "indefinitely postpone its ocean fertilization efforts" as a result of a "highly effective disinformation campaign waged by anti-offset crusaders" that turned public opinion against the effort and stymied attempts to raise capital to conduct ocean research trials. Our columnist linkurl:Glenn McGee;http://www.the-scientist.com/2007/11/1/33/1/ wrote about the company's efforts in our November, 2007 issue. The plan has been met with strong resistance from the scientific community, many of whom debunked or dismissed the company's claims. Planktos has called back its research vessel from the Portuguese island of Madeira, and "radically downsized" the staff. "The board of directors continues to believe in the urgent ecological necessity of its ocean restoration plans and the scientific speciousness of objections voiced to date. However, ideological hostility to and misrepresentations of this work will continue to stymie progress until the true gravity of our climatic and ocean crises is more widely understood." In November, a company representative sent a note to The Scientist complaining that a column by Glenn McGee and a linkurl:follow-up blog;http://www.the-scientist.com/blog/display/53848/ had dubbed the company's technology "nanotech." "I am unsure where this information originated, but we are not employing nanotechnology of any kind for our work," said Sarah Kelly, outreach doordinator at Planktos.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel